[{"Assets_0_FY_USD":238603000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":52384000.0,"NetIncomeLoss_4_FY_USD":31903000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":14768625.0,"StockholdersEquity_0_FY_USD":160762000.0,"EarningsPerShareBasic_1_FY_USD":0.86,"EarningsPerShareBasic_4_FY_USD":2.16,"Ticker":"EGRX","CIK":"827871","name":"EAGLE PHARMACEUTICALS, INC.","OfficialName":"Eagle Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"635235963.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190228"}]